Vertebral Artery Origin Treatment Via Endovascular Techniques Registry (VOTER)
ConditionVertebral Artery Stenosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorSt. Louis University
About this trial
A retrospective and prospective registry of patients admitted for stroke and evidence of Vertebral Artery Origin Stenosis (VAOS).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients between 18 and 90 years of age
Patient has experienced a posterior circulation ischemic event
Patient has angiographically confirmed bilateral vertebral artery origin disease (Hypoplasia, occlusion, or stenosis).
Patient has >50% stenosis on the side being targeted for therapy
Disqualifiers
Pregnant women
Contrast Indication to the use of anti-platelet drugs
There is tandem vertebral or basilar artery stenosis
The serum creatinin is >2.5
Trial population
Patients admitted for stroke and evidence of Vertebral Artery Origin Stenosis (VAOS).
Trial design
Design model
Case-only
Time perspective
Other
Treatments tested in this trial
Observational Prospective Registry
Other interventionThis is a prospective registry looking at patients admitted for stroke with evidence of Vertebral Artery Origin Stenosis. Patients clinical outcomes will be collected at 30 days and 1-year post-treatment and angiographic outcomes at 1-year post-treatment
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Incidence of recurrent stroke or death
Recurrent stroke of any type or death from any cause
Time frame
1 Year post-treatmentSecondary outcomes
1
Incidence of Restenosis
Restenosis in VAOS patients treated with drug-eluting stents.
Time frame
1 Year post-treatmentSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov